Neuehealth, INC

NeueHealth, Inc. has completed its take-private merger with an affiliate of New Enterprise Associates, with common stockholders receiving $7.33 per share in cash.

NeueHealth, Inc. announced an extension of the 'Outside Date' for its merger agreement with NH Holdings 2025, Inc. to December 23, 2025.

NeueHealth, Inc. announced strong second quarter 2025 financial results, driven by a significant increase in consumers served and continued Adjusted EBITDA profitability.

NeueHealth, Inc. announced the successful re-election of all ten director nominees and the ratification of Deloitte & Touche LLP as its independent auditor at its annual meeting of stockholders held on May 29, 2025.

NeueHealth, Inc. stockholders approved the merger agreement with NH Holdings 2025, Inc., paving the way for the company to become a private entity.

NeueHealth announces positive Adjusted EBITDA for the fifth consecutive quarter and a 51% increase in consumers served compared to Q1 2024, highlighting the success of its value-driven care model.

NeueHealth reports improved operating income and Adjusted EBITDA for Q2 2025, but faces substantial doubt about its ability to continue as a going concern.

NeueHealth's Q1 2025 results reveal a net loss of $10.8 million and highlight substantial doubt about the company's ability to continue as a going concern, despite ongoing efforts to drive positive cash flow and a pending merger with NH Holdings 2025, Inc.

NeueHealth reports its Q3 2024 results, highlighting a third consecutive quarter of Adjusted EBITDA profitability driven by its NeueCare and NeueSolutions segments.

NeueHealth's Q2 2024 results show a net loss of $61.9 million, but the company has secured a $150 million term loan facility.

NeueHealth's first quarter results show a shift towards value-based care with growth in NeueCare and NeueSolutions segments, despite an overall revenue decrease.

NeueHealth's 10-K filing reveals substantial doubt about its ability to continue as a going concern despite restructuring efforts and a pending merger agreement with NH Holdings.

NeueHealth's 2023 annual report details a strategic shift towards value-based care, focusing on its NeueCare and NeueSolutions segments after exiting the insurance business.

NeueHealth CFO Jay Matushak exchanged his equity holdings for units in the acquiring entity following the company's merger.

Bessemer Venture Partners and affiliated entities reported the disposition of all direct beneficial ownership in NeueHealth, Inc. common and preferred stock following its acquisition by NH Holdings 2025, Inc.

Stephen Kraus, a director of NeueHealth, Inc., reported the disposition of common and preferred stock following the company's acquisition by NH Holdings 2025, Inc. and a subsequent equity rollover.

NeueHealth GC & Corporate Secretary, Craig Jeffery Michael, exchanged his equity holdings for units in the acquiring entity's parent company following the October 2, 2025 merger.

Tomas Orozco, EVP of Consumer Care at NeueHealth, converted his common stock and restricted stock units into units of the acquiring entity following the company's merger.

NeueHealth Director Robert J. Sheehy reported the disposition of his shares in NeueHealth, Inc. as part of a merger where the company became a wholly-owned subsidiary of NH Holdings 2025, Inc.

NeueHealth, Inc. is set to hold its 2025 Annual Meeting of Stockholders virtually on May 29, 2025, to vote on director elections, auditor ratification, executive compensation, and other business matters.

NeueHealth, Inc. has entered into a definitive agreement to be acquired by NH Holdings 2025, Inc. for $7.33 per share in cash.

NeueHealth, Inc. has entered into a definitive agreement to be acquired by an affiliate of New Enterprise Associates (NEA) at $7.33 per share in cash, representing a 70% premium over the closing price on December 23, 2024.

NeueHealth, Inc. is holding its 2024 Annual Meeting of Stockholders virtually on May 2, 2024, to vote on key proposals including the election of directors and approval of an amended omnibus incentive plan.

NeueHealth, Inc. has completed its merger, becoming a wholly-owned subsidiary of an NEA affiliate, leading to its delisting from the NYSE and deregistration.

StepStone Group and its affiliates have ceased to be beneficial owners of NeueHealth, Inc. common stock following a business combination that converted their shares into cash at $7.33 per share.